赢创下调三季度业绩预期

Core Viewpoint - Evonik has revised its EBITDA expectations for Q3 2025, forecasting a range of €420 million to €460 million, reflecting a cautious market outlook and weaker demand across all business segments and end markets [1] Financial Performance - The adjusted EBITDA for Q2 2025 was reported at €509 million, benefiting from strong performance in April, but Q3 is expected to be lower due to ongoing economic challenges [1] - Market expectations for Q3 adjusted EBITDA are around €501 million, down from €577 million in the same period last year [1] - Q3 sales are projected to be approximately €3.4 billion, indicating a decline influenced by weak economic conditions [1] Future Outlook - Evonik has lowered its full-year adjusted EBITDA forecast for 2025 to about €1.9 billion, down from a previous range of €2 billion to €2.3 billion, with the latest market expectation at €1.96 billion [1] - The company anticipates a cash conversion rate between 30% and 40%, indicating challenges in managing working capital due to weak demand [1] - A complete quarterly report is scheduled for release on November 4, 2025 [1]